[What new on the way to the field of stroke prevention?].
Kaste
Markku
M
Helsingin yliopisto, HYKS:n neurologian klinikka. markku.kaste@hus.fi
Strandberg
Timo
T
Lindsberg
Perttu
P
Sivenius
Juhani
J
D017130:Angioplasty; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D016893:Carotid Stenosis / Q000150:complications / Q000601:surgery; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D009462:Neurology / Q000639:trends*; D015607:Stents; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D014815:Vitamins / Q000627:therapeutic use
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D005343:Fibrinolytic Agents; D014815:Vitamins